FALLS CHURCH, Va. (PRWEB) December 02, 2020
The pandemic has brought chaos to the pharmaceutical supply chain. What’s the solution? Focus on supplier management with this webinar.
Take a fresh look at the COVID-affected supply chain — not to mention new and revised ideas about how best to manage the supplier relationship — and one will know how to make suppliers become partners to success.
Attendees will explore the basics of the supplier relationship, with an emphasis on the best practices one must incorporate to manage it over time. Come away knowing how to manage problems by tackling them as they arise, conduct pandemic-era supplier audits (how to think about them, prepare for them and execute them) and craft that all-important quality agreement.
The presenter, Steven Lynn, Executive Vice President of Pharmaceuticals at Regulatory Compliance Associates, Inc., will share how to:
- Structure a pharmaceutical supplier agreement that incorporates specific clauses to assist in monitoring suppliers during the pandemic
- Take advantage of resources limited by COVID-19 within the global supply chain to maintain and/or increase productivity
- Emphasize the basics of the supplier relationship from its beginning, to best practices for managing it over time
- Use new technology to develop best practices for monitoring and overseeing supplier partnerships
- Conduct world-class supplier audits during the pandemic
- Retain quality oversight in your supplier relationships and deals
Manage supplier relationships during the pandemic and beyond. Learn to work with them more easily and ensure all products get to market.
Interested in registering multiple sites?
Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally
to learn about our special multisite discount.
Managing Your Pharmaceutical Suppliers During COVID-19:
Pandemic-Era Best Practices
An FDAnews Webinar
Wednesday, Dec. 16, 2020, 1:30 p.m.-3:00 p.m. EST
$287 per site
Easy Ways to Register:
By phone: 888.838.5578 or 703.538.7600
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews’ print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA’s complex and ever-changing regulations
Share article on social media or email: